The purchase price represents about 7.4 times the estimated revenue of the aqua business, Elanco said Monday in a
Merck will gain products for both warm- and cold-water species of fish that generated about $175 million revenue excluding corporate costs based on 2023 results, according to the statement. Elanco plans to used the $1.05 billion to $1.1 billion of expected after-tax proceeds ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.